Dont wait for hunger its probably not coming
Lancet Diabetes Endocrinol 4:525536 Flint A, Raben A, Astrup A, Holst JJ (1998) Glucagon-like peptide-1 promotes satiety and suppresses energy intake in humans
Dosage: Higher prescribed doses may increase your monthly costs
Reported outcomes include improved glucose tolerance, enhanced insulin sensitivity, and protective effects on pancreatic beta cells, which are important factors in metabolic regulation
Most current research-context subcutaneous protocols cite 300-500 mcg/day, but no published human pharmacokinetic study has formally evaluated the subcutaneous route
The starting Ozempic dose depends on your current Trulicity dose, typically beginning at 0.25mg or 0.5mg regardless of previous dosing